Overall, the lack of a link between clinical measures of disease severity in NHPs and the experimental conditions associated with exacerbated lung pathology is a limitation to their utility in predicting the risks of ADE associated with passive-antibody or vaccine interventions in humans
Peptide protocols must be evaluated and supervised by a licensed medical provider
These mechanisms involve key signaling pathways that determine not only cellular behavior but also the ability of the liver to rebuild
Clinically, G6PD deficiency has been linked to increased risk of Hepatitis A and B infections (99, 100), which may be related to deficient interferon responses in hepatocytes due to insufficient ROS generation by NADPH oxidase, as has been described for Dengue virus infection in G6PD-deficient monocytes (101)
Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, et al